Skip to main content
SpringerLink
Log in

Hearing loss and tinnitus—are funders and industry listening?

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Funding and publication in diabetes, hearing and tinnitus research.

References

  1. Sheridan, C. Nat. Biotechnol. 31, 575–576 (2013).

    Article  CAS  Google Scholar 

  2. Salomon, J.A. et al. Lancet 380, 2129–2143 (2012).

    Article  Google Scholar 

  3. Anonymous. Lancet 378, 99 (2011).

  4. King, H., Aubert, R.E. & Herman, W.H. Diabetes Care 21, 1414–1431 (1998).

    Article  CAS  Google Scholar 

  5. Nolan, C.J., Damm, P. & Prentki, M. Lancet 378, 169–181 (2011).

    Article  Google Scholar 

  6. Langguth, B. & Elgoyhen, A.B. Expert Opin. Pharmacother. 13, 2495–2509 (2012).

    Article  CAS  Google Scholar 

  7. Shargorodsky, J., Curhan, G.C. & Farwell, W.R. Am. J. Med. 123, 711–718 (2010).

    Article  Google Scholar 

  8. Friberg, E., Jansson, C., Mittendorfer-Rutz, E., Rosenhall, U. & Alexanderson, K. PLoS ONE 7, e29966 (2012).

    Article  CAS  Google Scholar 

  9. Hall, D.A. et al. BMC Health Serv. Res. 11, 302 (2011).

    Article  Google Scholar 

  10. Baguley, D., McFerran, D. & Hall, D. Tinnitus. Lancet doi:10.1016/S0140-6736(13)60142-7 (2 July 2013).

  11. Basile, A.S. et al. Nat. Med. 2, 1338–1343 (1996).

    Article  CAS  Google Scholar 

  12. Duan, M., Agerman, K., Ernfors, P. & Canlon, B. Proc. Natl. Acad. Sci. USA 97, 7597–7602 (2000).

    Article  CAS  Google Scholar 

  13. Puel, J.L., Pujol, R., Tribillac, F., Ladrech, S. & Eybalin, M. J. Comp. Neurol. 341, 241–256 (1994).

    Article  CAS  Google Scholar 

  14. Ruel, J., Bobbin, R.P., Vidal, D., Pujol, R. & Puel, J.L. Neuropharmacology 39, 1959–1973 (2000).

    Article  CAS  Google Scholar 

  15. Guitton, M.J. et al. J. Neurosci. 23, 3944–3952 (2003).

    Article  CAS  Google Scholar 

  16. Ruel, J. et al. J. Neurosci. 28, 7313–7323 (2008).

    Article  CAS  Google Scholar 

  17. Glowatzki, E. & Fuchs, P.A. Nat. Neurosci. 5, 147–154 (2002).

    Article  CAS  Google Scholar 

  18. Keen, E.C. & Hudspeth, A.J. Proc. Natl. Acad. Sci. USA 103, 5537–5542 (2006).

    Article  CAS  Google Scholar 

  19. Engineer, N.D. et al. Nature 470, 101–104 (2011).

    Article  Google Scholar 

  20. Middleton, J.W. et al. Proc. Natl. Acad. Sci. USA 108, 7601–7606 (2011).

    Article  CAS  Google Scholar 

  21. Yang, S., Weiner, B.D., Zhang, L.S., Cho, S.J. & Bao, S. Proc. Natl. Acad. Sci. USA 108, 14974–14979 (2011).

    Article  CAS  Google Scholar 

  22. Li, S., Choi, V. & Tzounopoulos, T. Proc. Natl. Acad. Sci. USA 110, 9980–9985 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank all organizations mentioned in this article that shared their expenditures, as well as the Hudspeth laboratory for invaluable support. C.R.C. is a recipient of post-doctoral fellowships from the Swiss National Science Foundation (SNF) nþ PBGEP3-125837 and the Schweizerischen Stiftung für medizinisch-biologische Stipendien (SSMBS) nþ PASMP3-136979 and has received funding from the Wenner Gren, Lars Hiertas Minne, Magnus Bergvalls Stiftelserna and Tysta Skolan. B.C. has received funding from the Vetenskapsrådet (VR), Forskningsrådet för arbetsliv och socialvetenskap (FAS), Karolinska Institutet and Tysta Skolan. B.L. has received research funding from the Tinnitus Research Initiative (TRI), the American Tinnitus Association (ATA), the Deutsche Forschungsgemeinschaft (DFG), the Bundesministerium für Bildung und Forschung (BMBF), AztraZeneca and Cerbomed. This article reflects the authors' personal opinions and not those of the cited organizations.

Author information

Authors and Affiliations

  1. Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

    Christopher R Cederroth & Barbara Canlon

  2. Department of Psychiatry and Psychotherapy, University of Regensburg, and Tinnitus Research Initiative, Regensburg, Germany

    Berthold Langguth

Authors
  1. Christopher R Cederroth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Canlon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Berthold Langguth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher R Cederroth.

Ethics declarations

Competing interests

B.L. has received honoraria and speakers' fee from ANM, AztraZeneca, Autifony, Lundbeck, Merz, Magventure, Novartis, Pfizer and Servier, and travel and accommodation payments from Lilly, Servier and Pfizer. B.L. is a member of the executive board of the Tinnitus Research Initiative.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cederroth, C., Canlon, B. & Langguth, B. Hearing loss and tinnitus—are funders and industry listening?. Nat Biotechnol 31, 972–974 (2013). https://doi.org/10.1038/nbt.2736

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2736

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation